CellCentric vs N-Zyme Biomedical

CellCentric vs N-Zyme Biomedical, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and N-Zyme Biomedical on 50/100.

CellCentric logo
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Try CellCentric
N-Zyme Biomedical logo
N-Zyme BiomedicalA biotechnology company focused on developing novel enzyme-based therapies for reflux disease.
Try N-Zyme Biomedical

Where each one leads

CellCentric

  • our overall score: 60/100 against 50/100
  • domain rating: 35/100 against 6/100
  • headcount: 53 against 5
  • funding raised: $375M against $4.6M
  • LinkedIn following: 28,695 against 296

N-Zyme Biomedical

Leads on none of the measures we hold for both companies.

At a glance

MeasureCellCentricN-Zyme Biomedical
What it isA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.
CategoryBiotechnology, Pharmaceuticals, Healthcare, BiotechBiotechnology, Pharmaceuticals, HealthTech, Biotech
Sells toBusiness modelB2BB2B
OfferingServicesPharmaceutical
Founded20032021
HeadquartersCambridge, United KingdomNewark, United States
StatusActiveActive

Size, funding and growth

MeasureCellCentricN-Zyme Biomedical
Employees535
Total funding$375M$4.6M
Latest roundSeries DSeries A
LinkedIn followers28,695296

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCellCentricN-Zyme Biomedical
StartupHub scoreOur 0-100 rating60/10050/100
Traction57/10041/100
Team60/100Not published
Search visibility44/10032/100
Quality68/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (32/100)F (31/100)
Domain ratingLink authority, 0-10035/1006/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCellCentricN-Zyme Biomedical
CDNCloudflareCloudflare
CMSWordPressWebflow
FrameworksJqueryNot detected
AnalyticsGoogle Analytics 4Hotjar

What users say

MeasureCellCentricN-Zyme Biomedical
Reddit sentimentThreads we trackNot published0 positive, 0 negative across 1 thread
N-Zyme Biomedical
“N-Zyme Biomedical Begins Phase 2 Trial of First Pepsin Inhibitor for Reflux Disease. What does this mean? Are they closer to the drug?”
r/LPR

CellCentric vs N-Zyme Biomedical: common questions

Which is better, CellCentric or N-Zyme Biomedical?

On our 0-100 score CellCentric rates higher (60/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do CellCentric and N-Zyme Biomedical compare on the numbers?

CellCentric leads on our overall score (60/100 against 50/100), domain rating (35/100 against 6/100), headcount (53 against 5), funding raised ($375M against $4.6M), LinkedIn following (28,695 against 296).

What do real users say about CellCentric and N-Zyme Biomedical?

N-Zyme Biomedical: 0 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/LPR.

Read the full CellCentric review and pricing or the N-Zyme Biomedical review and pricing. You can also browse other CellCentric alternatives we track.